CJC-1295/Ipamorelin
Research Compound (CAS 863288-34-0 / 170851-70-4)
A paired research combination of a GHRH-receptor analogue and a selective GHS-R agonist. Studied together due to complementary mechanisms — one stimulates GHRH receptors while the other acts on ghrelin receptors, producing additive GH pulse research data.
ESI-MS identity confirmed · Batch-specific COA included
Compound Specifications
863288-34-0 / 170851-70-4
3367.97 + 711.85 g/mol
Lyophilized Powder (1 vial)
-20°C
Available Sizes
We'll send one email when this item is restocked. No spam.
For laboratory research use only. Not for human or animal consumption. Must be 21+. This product is not intended to diagnose, treat, cure, or prevent any disease. Nothing on this site constitutes medical advice.
HPLC Verified
Reverse-phase HPLC purity analysis on every production batch. Raw chromatogram data included on COA.
ESI-MS Confirmed
Electrospray ionization mass spectrometry confirms molecular weight and sequence identity for every lot.
Batch-Specific COA
Each order ships with a certificate of analysis tied to its unique lot number — not a generic document.
More in Stacks
Stacks
Glow
99.0% purity
A proprietary research peptide blend formulated for in vitro extracellular matrix studies. Investigated for its role in fibrillar protein synthesis pathway modulation, reactive oxygen species scavenging assays, and dermal fibroblast receptor interaction in laboratory settings.
Stacks
Klow
99.0% purity
A proprietary research peptide blend studied for its potential role in metabolic regulation, cellular energy pathways, and stress-response modulation in controlled laboratory environments.
Stacks
Wolverine Stack
99.0% purity
A paired research combination of BPC-157 (5mg) and TB-500 (5mg), two of the most studied repair-pathway peptides. Investigated together for complementary mechanisms — BPC-157 for angiogenic and cytoprotective signaling, TB-500 for actin-sequestering and cellular migration — in preclinical and in vitro laboratory models.